Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
about
Neutrophil Extracellular Traps in ANCA-Associated VasculitisIdentification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitisUrinary biomarkers as a diagnostic tool for acute kidney injury.Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.Biomarkers of nephrotoxic acute kidney injuryTranscription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosisDecreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis.Proteinase 3 and prognosis of patients with acute myocardial infarction.Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?Nephroscreen: a diagnostic test for predicting acute renal failure?Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.Emerging urinary biomarkers in the diagnosis of acute kidney injurySerum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.Drug-induced nephrotoxicity and its biomarkers.Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis.The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity.Biomarkers of acute kidney injury.Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity.Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence.Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.Marginal-Zone B-Cells Are Main Producers of IgM in Humans, and Are Reduced in Patients With Autoimmune Vasculitis
P2860
Q26742162-181EAA7C-5296-4B47-8B9B-5BF364F7B83AQ30434677-5ABFD8E9-5F69-4BE2-867D-E809D83C329FQ30450879-086A7209-758F-4731-BEA6-27A65A691E17Q33684220-C70C81CC-C333-460B-9E2E-ADDE98904328Q33687717-C6266F32-3F63-4EBB-8D3B-7A4E7D73DF9AQ33921278-1A7F1836-181B-4C0F-B31D-8BB34FC7E060Q34189483-99E7F0FA-0ECB-4336-B478-D2A200511403Q34394925-AD2FC1D6-4526-4DB6-AD69-A2349ACD11CFQ35609175-C8C943EF-2A69-4AD4-8F70-F55F0E91A884Q36252152-0DC7F0EA-ED99-42F3-B2F5-49B1CEEAE235Q36713542-2DC8C1A9-E31C-4052-9EF9-2634D28D8EDFQ37010079-298382D2-13B0-4CEA-9DDA-36A650D4F193Q37170453-386D18AC-4435-45C5-874C-783545512146Q38153051-F5A377A4-06B1-449E-87BA-C7B1591B4AFAQ40409313-D23CA12E-B185-4F8D-BF80-0F4F3817BD96Q40501475-9D24C0A3-6A2C-49BD-9222-07B7C3D27FF1Q42553072-2176A915-7757-4D47-996D-7890D44F343BQ45282205-D7B3FA96-3D1C-4669-840A-FA7BEF2A6823Q46139426-6CC07719-715F-4E21-9CFD-C5F11CC745F4Q53428119-40566D2B-F9E4-4BB4-801A-320079A13E71Q54578801-C3BD6814-3CD6-4A32-8A7F-574BEC84246CQ54595726-1660B881-B294-49B4-BF85-DE275B3AFF5AQ57818271-81AC8729-997B-4F0A-8B00-5E8E00191D90
P2860
Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Increased circulating levels o ...... temic vasculitis in remission.
@en
Increased circulating levels o ...... temic vasculitis in remission.
@nl
type
label
Increased circulating levels o ...... temic vasculitis in remission.
@en
Increased circulating levels o ...... temic vasculitis in remission.
@nl
prefLabel
Increased circulating levels o ...... temic vasculitis in remission.
@en
Increased circulating levels o ...... temic vasculitis in remission.
@nl
P2093
P2860
P1476
Increased circulating levels o ...... temic vasculitis in remission.
@en
P2093
J Wieslander
M Segelmark
P2860
P304
P356
10.1046/J.1365-2249.2003.02083.X
P577
2003-03-01T00:00:00Z